MMJ The Reschedule Hearing Shut Out Got Vindicated: DEA’s Own Scientist Exposes the Agency’s Hypocrisy
DEA Barred the Only FDA Compliant Cannabis Drug Developer From Its Rescheduling Hearing-Then DEA's Own Scientist Identified the Very Evidence...
DEA Barred the Only FDA Compliant Cannabis Drug Developer From Its Rescheduling Hearing-Then DEA's Own Scientist Identified the Very Evidence...
WOODBRIDGE, N.J., July 24, 2026 /PRNewswire/ -- Care Career, a rapidly growing healthcare workforce technology organization, today announced the acquisition...
ORLANDO, Fla., July 24, 2026 /PRNewswire/ -- Award-winning author, entrepreneur, and Congenital Melanocytic Nevus (CMN) advocate Euran S. Daniels will deliver the...
Flying Eye Hospital project in Da Nang, supported by FedEx, advances locally led eye care and expands access across Central...
New report highlights circadian timing and control as one of the most powerful, and most overlooked, opportunities in personalized medicineNEW...
DELRAY BEACH, Fla., July 24, 2026 /PRNewswire/ -- According to MarketsandMarkets™, the Network Detection and Response (NDR) Market is projected to...
Issued on behalf of MindWalk Holdings Corp. (NASDAQ: HYFT)AUSTIN, Texas, July 24, 2026 /PRNewswire/ -- American News Group News Commentary...
Legendary Game-Worn Pieces from LeBron James, Kobe Bryant, Allen Iverson & Carmelo Anthony Close Online Tomorrow at 10:00 PM EST....
Toronto, Ontario--(Newsfile Corp. - July 24, 2026) - Optimind Pharma Corp. (CSE: OMND) ("Optimind" or the "Company") announces that it...
Clearwater, Florida--(Newsfile Corp. - July 24, 2026) - TelyRx Holdings Inc. (TSX: TELY) (OTCQX: TELYF) ("TelyRx" or the "Company"), a...
The watch list applies 18 qualitative KPIs developed specifically for emerging healthcare supply chain vendors, evaluating innovation, provider readiness, production...
SHELTON, CT / ACCESS Newswire / July 24, 2026 / NanoViricides, Inc. (NYSE American:NNVC) ("NanoViricides" or the "Company"), a clinical...
Sanofi announces decision not to submit amlitelimab in atopic dermatitis for global regulatory reviews Paris, July 24, 2026. Sanofi today...
PARIS, FRANCE, 24 JULY 2026 - Ipsen (Euronext: IPN; ADR: IPSEY) announced today that the Phase III BOLD trial evaluating...